These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31019677)

  • 1. Continuation of atypical antipsychotic medications in critically ill patients discharged from the hospital: a single-center retrospective analysis.
    Karamchandani K; Schoaps RS; Bonavia A; Prasad A; Quintili A; Lehman EB; Carr ZJ
    Ther Adv Drug Saf; 2019; 10():2042098618809933. PubMed ID: 31019677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pharmacy-Based Electronic Handoff Tool to Reduce Discharge Prescribing of Atypical Antipsychotics Initiated in the Intensive Care Unit: A Quality Improvement Initiative.
    Kram BL; Schultheis JM; Kram SJ; Cox CE
    J Pharm Pract; 2019 Aug; 32(4):434-441. PubMed ID: 29486664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital delirium treatment: Continuation of antipsychotic therapy from the intensive care unit to discharge.
    Flurie RW; Gonzales JP; Tata AL; Millstein LS; Gulati M
    Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S133-9. PubMed ID: 26582298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discharge from hospital with newly administered antipsychotics after intensive care unit delirium - Incidence and contributing factors.
    Lambert J; Vermassen J; Fierens J; Peperstraete H; Petrovic M; Colpaert K
    J Crit Care; 2021 Feb; 61():162-167. PubMed ID: 33171333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of atypical antipsychotic prescribing in the intensive care unit.
    Kram BL; Kram SJ; Brooks KR
    J Crit Care; 2015 Aug; 30(4):814-8. PubMed ID: 25887805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive analysis of the unwarranted continuation of antipsychotics for the management of ICU delirium during transitions of care: A multicenter evaluation across New Jersey.
    Dixit D; Barbarello Andrews L; Radparvar S; Adams C; Kumar ST; Cardinale M
    Am J Health Syst Pharm; 2021 Jul; 78(15):1385-1394. PubMed ID: 33895793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation Rate of Atypical Antipsychotics After Discharge When Initiated in the Intensive Care Unit.
    Farrokh S; Castle AC; Heavner M; Pisani MA
    J Pharm Pract; 2017 Jun; 30(3):342-346. PubMed ID: 27129913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of an Antipsychotic Discontinuation Bundle During Transitions of Care in Critically Ill Patients.
    D'Angelo RG; Rincavage M; Tata AL; Millstein LS; Gulati MS; Flurie RW; Gonzales JP
    J Intensive Care Med; 2019 Jan; 34(1):40-47. PubMed ID: 28049388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation of Newly Initiated Midodrine Therapy After Intensive Care and Hospital Discharge: A Single-Center Retrospective Study.
    Rizvi MS; Nei AM; Gajic O; Mara KC; Barreto EF
    Crit Care Med; 2019 Aug; 47(8):e648-e653. PubMed ID: 31107279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic utilization in the intensive care unit and in transitions of care.
    Marshall J; Herzig SJ; Howell MD; Le SH; Mathew C; Kats JS; Stevens JP
    J Crit Care; 2016 Jun; 33():119-24. PubMed ID: 26818629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic Prescribing in Older Adults after In-Hospital Initiation.
    Madey J; Tri S; Haines A; Zimmer S; Halpape K; Dumont Z
    Can J Hosp Pharm; 2024; 77(2):e3543. PubMed ID: 38720917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
    Shin S
    Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation of Opioid Therapy at Transitions of Care in Critically Ill Patients.
    Witcraft EJ; Gonzales JP; Seung H; Watt I; Tata AL; Yeung SYA; Heavner MS; Qato DM; Gulati MS; Millstein LS
    J Intensive Care Med; 2021 Aug; 36(8):879-884. PubMed ID: 32552281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Pharmacist Intervention on Inappropriate Continuations of Antipsychotics upon ICU Discharge.
    Dickman LT; Bauman K; Carter CK; Buchanan PM
    J Pharm Pract; 2024 Sep; ():8971900241281397. PubMed ID: 39226023
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and Risk Factors for Inappropriate Continuation of Proton Pump Inhibitors After Discharge From the Intensive Care Unit.
    Blackett JW; Faye AS; Phipps M; Li J; Lebwohl B; Freedberg DE
    Mayo Clin Proc; 2021 Oct; 96(10):2550-2560. PubMed ID: 33308869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Analysis of Psychoactive Medications Initiated in the ICU but Continued Beyond Discharge: A Pilot Study of Stewardship.
    Kovacic NL; Gagnon DJ; Riker RR; Wen S; Fraser GL
    J Pharm Pract; 2020 Dec; 33(6):760-767. PubMed ID: 30813837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loop diuretic use following fluid resuscitation in the critically ill.
    Alaskar MA; Brown JD; Voils SA; Vouri SM
    Am J Health Syst Pharm; 2022 Jan; 79(3):165-172. PubMed ID: 34553749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium.
    Jasiak KD; Middleton EA; Camamo JM; Erstad BL; Snyder LS; Huckleberry YC
    J Pharm Pract; 2013 Jun; 26(3):253-6. PubMed ID: 23184410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
    Wohlt PD; Hansen LA; Fish JT
    Ann Pharmacother; 2007 Oct; 41(10):1611-6. PubMed ID: 17848420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Age With Short-term and Long-term Mortality Among Patients Discharged From Intensive Care Units in France.
    Atramont A; Lindecker-Cournil V; Rudant J; Tajahmady A; Drewniak N; Fouard A; Singer M; Leone M; Legrand M
    JAMA Netw Open; 2019 May; 2(5):e193215. PubMed ID: 31074809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.